Correction to A Chemoproteomic Platform To Assess Bioactivation

Addition/Correction Cite This: Chem. Res. Toxicol. 2017, 30, 2093-2093

pubs.acs.org/crt

Correction to A Chemoproteomic Platform To Assess Bioactivation Potential of Drugs Rui Sun,# Fuguo Shi,# Keke Liu, Ling Fu, Caiping Tian, Yong Yang, Keri A. Tallman, Ned A. Porter, and Jing Yang* Chem. Res. Toxicol. 2017, 30, 1797−1803. DOI: 10.1021/acs.chemrestox.7b00183 n the original article, we erroneously calculated the KI and kinact values, which should be corrected as 125.4 μM and 0.12 min−1, respectively. In Figures 3 and S3, the captions of the log10-scaled y-axis need to be changed to “Remaining activity (%)”. In addition, the numbers (2, 4, and 6) labeled on the yaxis of the inset of Figure 3B need to be corrected as 20, 40, and 60, respectively. Moreover, the equation in Figure 3B needs to be changed to “y = 1089.4x + 8.6881 (R2 = 0.9869)”.

I

■

AUTHOR INFORMATION

ORCID

Jing Yang: 0000-0001-8486-273X Author Contributions #

These authors contributed equally to this work.

■

ACKNOWLEDGMENTS Although these alterations did not change the interpretation of the data or the study results, the authors apologize for the errors and any inconvenience that they may have caused. The authors would also like to thank Dr. Patrick M. Dansette at Université Paris-Descartes for discovering our mistakes.

Published: November 7, 2017 © 2017 American Chemical Society

2093

DOI: 10.1021/acs.chemrestox.7b00297 Chem. Res. Toxicol. 2017, 30, 2093−2093